CD69 and neoplasm: Despite this, the percentage of CD69-expressing CD8+ lymphocytes in the spleens of the affective treatment group with tumours smaller than 300 mg was statistically higher than the mild and no-effect groups (>300 mg tumour size) and isotype control [48].